FDA Compliance

Inspection-ready systems,
made practical.

We help sterile and non-sterile drug manufacturers respond to FDA findings, prepare for inspections, and build regulatory submissions that hold up to scrutiny — without losing sight of the business objective.

01

Service
detail

When the FDA raises a concern, the response matters as much as the fix.

A Form 483 observation or Warning Letter is rarely just a paperwork problem — it's a signal that your quality system needs a closer look. We help you respond quickly and credibly, then build the underlying systems so the same issue doesn't resurface at your next inspection.

Back to all services
FDA inspection readiness consulting for pharmaceutical manufacturers

What we help with

The right response, review,
and quality system.

Support that helps put the right response, review, and quality system around critical regulatory priorities.

  • Form 483 & Warning Letter responses
  • Remediation plans
  • Mock pre-approval audits
  • Vendor audits & due diligence
  • Regulatory submissions review

Service breakdown

From finding to fix.

01

Form 483 & Warning Letter Responses

We help you draft clear, defensible, and technically sound responses to FDA observations — with realistic timelines and CAPA commitments your team can actually deliver on.

02

Remediation Plans

Beyond the initial response, we help you design and execute a remediation plan that addresses root cause, not just the symptom the FDA flagged.

03

Mock Pre-Approval Audits

Before the FDA arrives, we run a mock audit that mirrors real inspection conditions — surfacing gaps in documentation, procedures, and facility readiness while there's still time to fix them.

04

Vendor Audits & Due Diligence

We assess suppliers, CMOs, and contract testing labs against CGMP expectations, giving you clear visibility into third-party risk before it becomes your risk.

05

Regulatory Submissions Review

We review submissions for regulatory accuracy and completeness, helping reduce the risk of delays, deficiency letters, or follow-up information requests.

Who this is for

Built for sterile and non-sterile
manufacturers alike.

Whether you manufacture sterile injectables, ophthalmic and otic products, oral dosage forms, or transdermal and transmucosal products, our FDA compliance support adapts to your facility, product type, and regulatory history — branded, generic, OTC, or compounded.

Talk to an expert

How we work

A structured path from
finding to fix.

The same four-step engagement path used across Steripharm services, contextualized to FDA compliance.

  1. 01

    Frame

    We review the FDA finding or inspection concern and clarify exactly what's being asked of you.

  2. 02

    Focus

    We prioritize the systems, records, and risks most relevant to the observation.

  3. 03

    Act

    We support the response, remediation, or audit itself — hands-on, not just advisory.

  4. 04

    Embed

    We help the fix become a lasting part of your quality system, not a one-time patch.

FAQ

FDA compliance — common questions.

What manufacturers ask most about responses, audits, and remediation.

Ask a different question
How quickly can you help after we receive a Form 483 or Warning Letter?

FDA response timelines are tight, so we prioritize an initial review and response plan as soon as you engage us — typically within days, not weeks.

Can you conduct a mock inspection before our facility is audited?

Yes. Mock pre-approval audits are one of our core services, designed to surface gaps before the FDA does.

Do you review vendor and CMO quality systems, not just our own?

Yes. Vendor audits and due diligence are part of our FDA compliance service, since third-party risk becomes your risk during an inspection.

Is this service only for major violations, or can you help with smaller compliance gaps too?

Both. We support everything from a single observation response to a full remediation program.

Related services

Explore the rest of our capabilities.

Quality assurance

Better continuity for manufacturing and product quality.

From disposition and batch record review to investigations, CAPA, technology transfer, method validation, and environmental monitoring.

Explore Quality Assurance & Control
All services

Two focused service tracks for FDA-regulated manufacturers.

See how FDA compliance and quality assurance work together across the full Steripharm service offering.

View all services

Start with clarity

Build sustainable compliance into every next step.

Talk with Steripharm Solutions about your FDA compliance objective.

Contact our team